Cognitive reserve in relation to abeta42 in patients converting from MCI to Dementia - A follow-up report

Dementia and Geriatric Cognitive Disorders

Volumn 28, Issue 2, 2009, Pages 110-115

  Rolstad, S ^a   Nordlund, A ^a   Eckerstrom C ^a   Gustavsson, M H ^a   Zetterberg, H ^a   Wallin, A ^a  

^a Institute of Neuroscience and Physiology   (Sweden)

Author keywords

Biomarkers; Dementia; Education; Mild cognitive impairment; Neuropsychology

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; BIOLOGICAL MARKER; TAU PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; ARTICLE; COGNITION; CONTROLLED STUDY; DEMENTIA; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; POST HOC ANALYSIS; PRIORITY JOURNAL; SCORING SYSTEM; STUDENT T TEST;

AGED; AMYLOID BETA-PROTEIN; BIOLOGICAL MARKERS; COGNITION; COGNITION DISORDERS; DEMENTIA; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PEPTIDE FRAGMENTS;

EID: 68549133458     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000234912     Document Type: Article

References (32)

1. Stern Y: What is cognitive reserve? Theory and research application of the reserve concept. J Int Neuropsychol Soc 2002; 8: 448-460.
2. Stern Y: Cognitive reserve and Alzheimer disease. Alzheimer Dis Assoc Disord 2006; 20:S69-S74. (Pubitemid 44265854)
3. Launer LJ, Andersen K, Dewey ME, Letenneur L, Ott A, Amaducci LA, Brayne C, Copeland JR, Dartigues JF, Kragh-Sorensen P, Lobo A, Martinez-Lage JM, Stijnen T, Hofman A: Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. EURODEM incidence research group and work groups. European studies of dementia. Neurology 1999; 52: 78-84.
4. Stern Y, Gurland B, Tatemichi TK, Tang MX, Wilder D, Mayeux R: Influence of education and occupation on the incidence of Alzheimer's disease. JAMA 1994; 271: 1004-1010.
5. Albert MS, Jones K, Savage CR, Berkman L, Seeman T, Blazer D, Rowe JW: Predictors of cognitive change in older persons: Macarthur studies of successful aging. Psychol Aging 1995; 10: 578-589.
6. Scarmeas N, Albert SM, Manly JJ, Stern Y: Education and rates of cognitive decline in incident Alzheimer's disease. J Neurol Neurosurg Psychiatry 2006; 77: 308-316.
7. Kemppainen NM, Aalto S, Karrasch M, Nagren K, Savisto N, Oikonen V, Viitanen M, Parkkola R, Rinne JO: Cognitive reserve hypothesis: Pittsburgh Compound B and fluorodeoxyglucose positron emission tomography in relation to education in mild Alzheimer's disease. Ann Neurol 2008; 63: 112-118.
8. Alexander GE, Furey ML, Grady CL, Pietrini P, Brady DR, Mentis MJ, Schapiro MB: Association of premorbid intellectual function with cerebral metabolism in Alzheimer's disease: implications for the cognitive reserve hypothesis. Am J Psychiatry 1997; 154: 165-172.
9. Scarmeas N, Zarahn E, Anderson KE, Ha-beck CG, Hilton J, Flynn J, Marder KS, Bell KL, Sackeim HA, Van Heertum RL, Moeller JR, Stern Y: Association of life activities with cerebral blood flow in Alzheimer disease: implications for the cognitive reserve hypothesis. Arch Neurol 2003; 60: 359-365.
10. Bennett DA, Schneider JA, Wilson RS, Bienias JL, Arnold SE: Education modifies the association of amyloid but not tangles with cognitive function. Neurology 2005; 65: 953-955.
11. Rolstad S, Nordlund A, Eckerstrom C, Gustavsson MH, Zetterberg H, Wallin A: Biomarkers in relation to cognitive reserve in patients with mild cognitive impairment - proof of concept. Dement Geriatr Cogn Disord 2009; 27: 194-200.
12. Blennow K: Cerebrospinal fluid protein biomarkers for Alzheimer's disease. NeuroRx 2004; 1: 213-225.
13. Nordlund A, Rolstad S, Hellstrom P, Sjogren M, Hansen S, Wallin A: The Goteborg MCI study: mild cognitive impairment is a heterogeneous condition. J Neurol Neurosurg Psychiatry 2005; 76: 1485-1490.
14. Reisberg B, Ferris SH, de Leon MJ, Crook T: Global deterioration scale (GDS). Psychopharmacol Bull 1988; 24: 661-663.
15. Erkinjuntti T, Inzitari D, Pantoni L, Wallin A, Scheltens P, Rockwood K, Roman GC, Chui H, Desmond DW: Research criteria for subcortical vascular dementia in clinical trials. J Neural Transm Suppl 2000; 59: 23-30. (Pubitemid 30479402)
16. McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, Aarsland D, Arai H, Ballard CG, Boeve B, Burn DJ, Costa D, Del Ser T, Dubois B, Galasko D, Gauthier S, Goetz CG, Gomez-Tortosa E, Halliday G, Hansen LA, Hardy J, Iwatsubo T, Kalaria RN, Kaufer D, Kenny RA, Korczyn A, Kosaka K, Lee VM, Lees A, Litvan I, Londos E, Lopez OL, Minoshima S, Mizuno Y, Molina JA, Mukaetova-Ladinska EB, Pasquier F, Perry RH, Schulz JB, Trojanowski JQ, Yamada M: Diagnosis and management of dementia with Lewy bodies: third report of the DLB consortium. Neurology 2005; 65: 1863-1872.
17. Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, Freedman M, Kertesz A, Robert PH, Albert M, Boone K, Miller BL, Cummings J, Benson DF: Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998; 51: 1546-1554.
18. Assessment: neuropsychological testing of adults. Considerations for neurologists. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 1996; 47: 592-599.
19. Blennow K, Wallin A, Agren H, Spenger C, Siegfried J, Vanmechelen E: Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease? Mol Chem Neuropathol 1995; 26: 231-245.
20. Andreasen N, Hesse C, Davidsson P, Minthon L, Wallin A, Winblad B, Vanderstichele H, Vanmechelen E, Blennow K: Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease. Arch Neurol 1999; 56: 673-680.
21. Andreasen N, Minthon L, Davidsson P, Vanmechelen E, Vanderstichele H, Winblad B, Blennow K: Evaluation of CSF-tau and CSFabeta42 as diagnostic markers for Alzheimer disease in clinical practice. Arch Neurol 2001; 58: 373-379.
22. Mayeux R: Epidemiology of neurodegeneration. Annu Rev Neurosci 2003; 26: 81-104.
23. Bell RD, Zlokovic BV: Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease. Acta Neuropathol 2009; 118: 103-113.
24. Skoog I, Davidsson P, Aevarsson O, Vanderstichele H, Vanmechelen E, Blennow K: Cerebrospinal fluid beta-amyloid 42 is reduced before the onset of sporadic dementia: a pop-ulation-based study in 85-year-olds. Dement Geriatr Cogn Disord 2003; 15: 169-176.
25. Zetterberg H, Pedersen M, Lind K, Svensson M, Rolstad S, Eckerstrom C, Syversen S, Mattsson UB, Ysander C, Mattsson N, Nordlund A, Vanderstichele H, Vanmechelen E, Jonsson M, Edman A, Blennow K, Wallin A: Intra-individual stability of CSF biomarkers for Alzheimer's disease over two years. J Alzheimers Dis 2007; 12: 255-260. (Pubitemid 350179256)
26. Wilson RS, Hebert LE, Scherr PA, Barnes LL, Mendes de Leon CF, Evans DA: Educational attainment and cognitive decline in old age. Neurology 2009; 72: 460-465.
27. Albert SM, Teresi JA: Reading ability, education, and cognitive status assessment among older adults in Harlem, New York City. Am J Public Health 1999; 89: 95-97.
28. Rentz DM, Huh TJ, Faust RR, Budson AE, Scinto LF, Sperling RA, Daffner KR: Use of IQ-adjusted norms to predict progressive cognitive decline in highly intelligent older individuals. Neuropsychology 2004; 18: 38-49.
29. Rolstad S, Nordlund A, Gustavsson MH, Eckerstrom C, Klang O, Hansen S, Wallin A: The Swedish national adult reading test (NART-SWE): a test of premorbid IQ. Scand J Psychol 2008; 49: 577-582.
30. Katzman R, Aronson M, Fuld P, Kawas C, Brown T, Morgenstern H, Frishman W, Gidez L, Eder H, Ooi WL: Development of dementing illnesses in an 80-year-old volunteer cohort. Ann Neurol 1989; 25: 317-324.
31. Rentz DM, Sardinha LM, Huh TJ, Searl MM, Daffner KR, Sperling RA: IQ-based norms for highly intelligent adults. Clin Neuropsychol 2006; 20: 637-648.
32. Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, Meguro K, O'Brien J, Pasquier F, Robert P, Rossor M, Salloway S, Stern Y, Visser PJ, Scheltens P: Research criteria for the diagnosis of Alzheimer's disease: Revising the NINCDS-ADRDA criteria. Lancet Neurol 2007; 6: 734-746.